JenaValve Technology has announced that it will join the American Society of Echocardiography (ASE) Industry Roundtable in 2024.
In a press release, JenaValve said that the organisations will work together to drive increased awareness and education of cardiac imaging for the detection and diagnosis of aortic regurgitation (AR).
The ASE Industry Roundtable (IRT) is a partnership between industry representatives, practitioners, and scientists with the shared objectives of improving patient care through innovation and setting practice standards for cardiovascular ultrasound.
“Echocardiography is fundamental to the detection and diagnosis of AR. We are excited to support ASE to contribute directly to their education efforts on the importance of cardiac imaging, which can allow physicians to better identify AR patients for potential treatment,” said John Kilcoyne, chief executive officer of JenaValve. “Accurately identifying the AR patient population through imaging is an important step in raising awareness for this unmet clinical need.”
“We are pleased to be partnering with JenaValve as leaders in the AR space. They bring a unique perspective to echocardiography for heart valve disease,” said Benjamin Eidem, president of ASE. “This partnership helps both ASE and JenaValve accomplish our shared goal of improving patient care for those suffering from AR.”